Skip to main content

Illumina Inc(ILMN-Q)

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Illumina's Board of Directors elects two experienced Independent Directors to Board

PR Newswire - Fri Jun 2, 6:30AM CDT

Stephen P. MacMillan, Hologic CEO, named non-executive Chair of Illumina's Board

Scott B. Ullem, CFO of Edwards Lifesciences, also named to Board

SAN DIEGO, June 2, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of governance changes consistent with the goal of enhancing long-term shareholder value.


Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.